Abeona Therapeutics® 公布业务进展,Zevaskyn® 商业上市势头持续增强

美股速递
Mar 09

Abeona Therapeutics Inc 近期发布了业务更新,重点强调了其基因疗法 Zevaskyn® 在商业上市过程中不断积累的积极势头。公司表示,相关准备工作正在稳步推进,市场初步反馈良好,为后续的商业化成功奠定了坚实基础。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10